ULK1 and cancer: The combination of wogonin and oxaliplatin demonstrated a possible reduction in cancer cell survival through alteration of phospho‐ULK1 (Ser555) and phospho‐ULK1 expression in the zebrafish xenograft model (Ruibin et al. 2017).